- Home
- MAMA vs AVIR Comparison
MAMA vs AVIR Comparison
Compare MAMA & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- AVIR
- Stock Information
- Founded
- MAMA 2010
- AVIR 2012
- Country
- MAMA United States
- AVIR United States
- Employees
- MAMA N/A
- AVIR N/A
- Industry
- MAMA Specialty Foods
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- MAMA Consumer Staples
- AVIR Health Care
- Exchange
- MAMA Nasdaq
- AVIR Nasdaq
- Market Cap
- MAMA 391.2M
- AVIR 290.4M
- IPO Year
- MAMA N/A
- AVIR 2020
- Fundamental
- Price
- MAMA $10.16
- AVIR $2.89
- Analyst Decision
- MAMA Strong Buy
- AVIR Hold
- Analyst Count
- MAMA 2
- AVIR 1
- Target Price
- MAMA $14.00
- AVIR $6.00
- AVG Volume (30 Days)
- MAMA 309.1K
- AVIR 244.4K
- Earning Date
- MAMA 09-08-2025
- AVIR 11-06-2025
- Dividend Yield
- MAMA N/A
- AVIR N/A
- EPS Growth
- MAMA N/A
- AVIR N/A
- EPS
- MAMA 0.11
- AVIR N/A
- Revenue
- MAMA $135,566,000.00
- AVIR N/A
- Revenue This Year
- MAMA $17.24
- AVIR N/A
- Revenue Next Year
- MAMA $9.95
- AVIR N/A
- P/E Ratio
- MAMA $90.30
- AVIR N/A
- Revenue Growth
- MAMA 19.34
- AVIR N/A
- 52 Week Low
- MAMA $5.50
- AVIR $2.46
- 52 Week High
- MAMA $9.98
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- MAMA 67.31
- AVIR 48.12
- Support Level
- MAMA $9.23
- AVIR N/A
- Resistance Level
- MAMA $9.95
- AVIR $3.33
- Average True Range (ATR)
- MAMA 0.56
- AVIR 0.13
- MACD
- MAMA 0.10
- AVIR -0.16
- Stochastic Oscillator
- MAMA 99.78
- AVIR 79.49
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).